Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
61.22(c) 61.46(c) 60.92(c) 62.3(c) 61.92(c) Last
4 937 395 3 982 628 3 990 307 6 553 255 4 236 232 Volume
-0.37% +0.39% -0.88% +2.27% -0.61% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
03/03 | 09:20amPresentation
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 15 132 M
EBIT 2015 3 098 M
Net income 2015 2 749 M
Finance 2015 1 910 M
Yield 2015 2,39%
Sales 2016 16 821 M
EBIT 2016 4 260 M
Net income 2016 3 766 M
Finance 2016 2 806 M
Yield 2016 2,51%
PER 2015 36,60
PER 2016 27,35
EV / Sales 2015 6,68x
EV / Sales 2016 5,95x
Capitalization 102 918 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
01:47a BRISTOL MYERS SQUIBB : Announces Dividend
01:47a BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Supplemental Bi..
01:44a BRISTOL MYERS SQUIBB : FDA Oks Biologics Licensing Application for Opdivo (nivol..
01:31a BRISTOL MYERS SQUIBB : Signs Exclusive Agreement with Bavarian Nordic for PROSTV..
03/03 BRISTOL MYERS SQUIBB : Hepatitis C cure rate of 97 per cent announced in study o..
03/03 IPSEN : Dominique Laymand is appointed as Ipsen's Senior Vice President, Chief E..
03/03 BRISTOL MYERS SQUIBB : Releases Study Data on Investigational HIV-1 Maturation I..
03/02 BRISTOL MYERS SQUIBB : FDA accepts Bristol-Myers' BLA for Opdivo to treat advanc..
More news
Sector news Pharmaceuticals - NEC
01:57aDJToyota Taps First Foreign Vice President
03/03 JOHNSON & JOHNSON : Announces Binding Offer from Cardinal Health to Acquire Cord..
03/03 ACTAVIS : Announces Pricing of Public Offering of Senior Notes in Connection wit..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF